SUSMED 2021
Tokyo, JP · Founded 2015 · 3 known investors
Find your way into SUSMED 2021
31 people in our graph share verified history with the SUSMED 2021 team — schools, employers, funds. One of them is your warm intro.
Kyoko Matsumotounlockedknows Taro Ueno, M.D., Ph.D · together at Tohoku University (overlapped)
×7knows the team · via Tohoku University
×3knows the team · via Japan Society for the Promotion of Science
knows the team · via Kumamoto University
SUSMED (サスメド株式会社) develops therapeutic apps (digital therapeutics) and a blockchain-based clinical trial system, and provides medical data analysis using statistics and machine learning. The Japanese company serves pharmaceutical companies and medical research institutions, including a marketed prescription app for insomnia.
Founders & leadership
SUSMED 2021 was founded in 2015 by 上野 太郎 and Taro Ueno, M.D., Ph.D.
上太
上野 太郎代表取締役社長
TU
Taro Ueno, M.D., Ph.DinFounderTaro Ueno is a physician and Ph.D. holder who founded SUSMED, a company developing digital therapeutics and blockchain-based clinical trial systems for pharmaceutical companies and medical research institutions.
本智
本橋 智光取締役 CTO
Investors · 3
Frequently asked questions
- What does SUSMED 2021 do?
- SUSMED (サスメド株式会社) develops therapeutic apps (digital therapeutics) and a blockchain-based clinical trial system, and provides medical data analysis using statistics and machine learning. The Japanese company serves pharmaceutical companies and medical research institutions, including a marketed prescription app for insomnia.
- Who founded SUSMED 2021?
- SUSMED 2021 was founded by 上野 太郎, Taro Ueno, M.D., Ph.D in 2015.
- Who are SUSMED 2021's investors?
- SUSMED 2021's investors include Beyond Next Ventures, DIMENSION, Sony Ventures Corporation.
- Where is SUSMED 2021 headquartered?
- SUSMED 2021 is headquartered in Tokyo, JP.